Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
-
Authors :
Sapp JL; From the Department of Medicine, QEII Health Sciences Centre and Dalhousie University, Halifax, NS (J.L.S., R.P.), University of Ottawa Heart Institute, Ottawa (G.A.W., P.B.N.), Institut Universitaire de Cardiologie et de Pneumologie de Québec, Quebec, QC (L.B., J.-F.S.), Institut de Cardiologie de Montréal (B.T., L.R.), McGill University Health Center and Hôpital Sacré-Coeur de Montréal (V.E.), and Centre Hospitalier de L'Universite de Montréal (J.-M.R.), Montreal, Western University, London, ON (L.G., P.L.-S., A.S.L.T.), the Division of Cardiology, Royal Columbian Hospital, New Westminster, BC (S.K.T.), Royal Jubilee Hospital, Victoria, BC (L.D.S.), Libin Cardiovascular Institute of Alberta, Calgary (G.D.V.), Population Health Research Institute, Hamilton, ON (J.S.H.), Kingston General Hospital, Kingston, ON (D.R.), and Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC (J.-F.R.) - all in Canada; and the Cardiovascular Division, Brigham and Women's Hospital, Boston (W.G.S.).
Subjects: Catheter Ablation*/Catheter Ablation*/Catheter Ablation*/adverse effects; Amiodarone/Amiodarone/Amiodarone/*administration & dosage ; Anti-Arrhythmia Agents/Anti-Arrhythmia Agents/Anti-Arrhythmia Agents/*administration & dosage
-
Source:
The New England journal of medicine [N Engl J Med] 2016 Jul 14; Vol. 375 (2), pp. 111-21. Date of Electronic Publication: 2016 May 05.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model:
Record details
